YWHAE antibody
Quick Overview for YWHAE antibody (ABIN7603844)
Target
See all YWHAE AntibodiesReactivity
Host
Clonality
Conjugate
Application
Clone
-
-
Purpose
- Anti-14-3-3 epsilon YWHAE Rabbit Monoclonal Antibody
-
Characteristics
- Anti-14-3-3 epsilon YWHAE Rabbit Monoclonal Antibody (ABIN7603844). Tested in WB, IHC, ICC/IF, Flow Cytometry applications. This antibody reacts with Human, Mouse, Rat.
-
Purification
- Affinity-chromatography
-
Immunogen
- A synthesized peptide derived from human 14-3-3 epsilon
-
Isotype
- IgG
-
-
-
-
Application Notes
-
WB 1:1000-1:2000
IHC 1:50-1:200
ICC/IF 1:50-1:200
FC 1:50 -
Restrictions
- For Research Use only
-
-
-
Format
- Liquid
-
Reconstitution
- Restore with deionized water (or equivalent) for reconstitution volume of 1.0 mL
-
Concentration
- Lot specific
-
Buffer
- Rabbit IgG in phosphate buffered saline, pH 7.4, 150 mM NaCl, 0.02 % sodium azide and 50 % glycerol, 0.4-0.5 mg/mL BSA.
-
Preservative
- Sodium azide
-
Precaution of Use
- This product contains Sodium azide: a POISONOUS AND HAZARDOUS SUBSTANCE which should be handled by trained staff only.
-
Storage
- 4 °C,-20 °C
-
Storage Comment
- Store at -20°C for one year. For short term storage and frequent use, store at 4°C for up to one month. Avoid repeated freeze-thaw cycles.
-
-
- YWHAE (14-3-3 epsilon (YWHAE))
-
Alternative Name
- YWHAE
-
Background
-
Synonyms: 14-3-3 protein epsilon,14-3-3E,YWHAE,
Tissue Specificity: Detected in endothelial cells in vascular tissue throughout the body. May appear at the surface of neural crest cells during their embryonic migration. Appears to be limited to vascular smooth muscle in normal adult tissues. Associated with tumor progression and the development of metastasis in human malignant melanoma. Expressed most strongly on metastatic lesions and advanced primary tumors and is only rarely detected in benign melanocytic nevi and thin primary melanomas with a low probability of metastasis.
-
Molecular Weight
- 120 kDa
-
UniProt
- P62258
-
Pathways
- Neurotrophin Signaling Pathway, Myometrial Relaxation and Contraction, M Phase
Target
-